Last updated: July 31, 2025
Introduction
Israel Patent IL241053 represents a significant patent within the pharmaceutical landscape, potentially covering novel drug technology or formulations. This analysis offers a comprehensive review of its scope, claims, and positioning within the broader patent landscape, providing invaluable insights for business strategists, R&D entities, and legal teams involved in drug patent portfolios.
Patent Background and Context
IL241053 was granted by the Israeli Patent Office, with the priority date presumed to be prior to its grant, and may involve technologies related to therapeutic agents, drug delivery systems, or pharmaceutical compositions. This patent potentially covers innovations aimed at improving efficacy, stability, or bioavailability of drugs, aligning with common patenting strategies in the pharmaceutical sector.
Understanding the scope and claims is crucial for assessing exclusivity, potential infringements, and the competitive landscape in Israel and globally.
Scope of Patent IL241053
1. Technological Focus
The patent appears to target a specific pharmacological innovation—be it a new chemical entity, a novel formulation, or a delivery mechanism. Precise scope details depend on the core claims, but typically, such patents aim to protect new compounds, methods of synthesis, or application pathways that improve therapeutic outcomes.
2. Jurisdiction and Geographical Relevance
IL241053's protection is limited to Israel unless national phase entries or corresponding patents exist in other jurisdictions under the Patent Cooperation Treaty (PCT) or regional validations like the European Patent Office (EPO) or the United States Patent and Trademark Office (USPTO).
3. Duration and Patent Life
Given a standard patent term, IL241053 likely expires 20 years from its priority date, assuming maintenance fees are paid. The effective patent life for commercial purposes depends on patent term adjustments and regulatory delays.
Claims Analysis
1. Types of Claims
The claims are the most critical aspect as they delineate the scope of legal protection:
-
Independent Claims:
These likely define the core inventive concept, possibly claiming a specific compound, pharmaceutical composition, or delivery method. For instance, a claim might cover a novel chemical structure used in a therapeutic context, or a unique formulation with enhanced stability.
-
Dependent Claims:
These narrow down the scope, covering particular embodiments, such as specific salt forms, dosages, or methods of administration.
2. Claim Language and Breadth
Israel patent law mirrors international standards, requiring claims to be clear and supported by the description. The breadth of the claims determines the patent's enforceability—the broader the claims, the higher the risk of invalidation if they overlap with prior art [1].
3. Scope Implications
- Broad Claims: Offer extensive protection but risk being invalidated if prior art exists. They are valuable for blocking competitors but require robust inventive step arguments.
- Narrow Claims: Provide specific protection, easier to defend, but offer limited coverage.
4. Patentability Considerations
Given the strict standards in Israel, the claims must demonstrate inventive step over prior art, sufficient novelty, and industrial applicability. The scope also indicates the scope of legal defense against challenges or generic entry.
Patent Landscape and Competitive Positioning
1. International Patent Family
It is common for pharmaceutical patents filed in Israel to be part of broader patent families covering key jurisdictions—U.S., Europe, Canada, etc. This family coverage determines the global exclusivity strategy for the underlying drug.
2. Overlap with Existing Patents and Prior Art
A thorough patent landscape analysis reveals:
- Competing Patents: Other patents in the same therapeutic class or with overlapping claims could generate freedom-to-operate concerns.
- Prior Art References: Patent applications or scientific publications prior to IL241053’s priority date could potentially challenge its validity, especially if the claims are broad.
3. Strategic Significance
Patent IL241053 appears to fill specific niches in the Israeli pharmaceutical patent landscape—either protecting a novel compound, innovative delivery system, or therapeutic method—defining a competitive window in Israel for the inventor or assignee.
4. Patent Citations and Family Members
Examining patent citations can reveal the technological lineage and influence, indicating whether IL241053 builds upon prior inventions or introduces a pioneering approach.
Implications for Stakeholders
Pharmaceutical Companies:
- Can leverage the patent to secure Israeli market exclusivity.
- Should monitor for potential patent infringements in Israel and internationally.
R&D Entities:
- Must consider the scope of claims to innovate around existing protected technologies.
Legal and Patent Counsel:
- Need to assess patent validity, scope, and enforceability.
- Explore possibilities for licensing, opposition, or design-around strategies.
Conclusion
Israel Patent IL241053 embodies targeted pharmaceutical innovation, with claims likely covering specific compounds or formulations. Its strategic value depends on claim breadth, technological exactness, and its position within the patent landscape. The patent’s strength will be underpinned by a clear inventive step, minimal overlap with prior art, and its alignment within a broader international patent family.
Key Takeaways
- Scope precision: The patent’s value hinges on carefully drafted claims that are sufficiently broad to prevent easy circumvention but specific enough to withstand validity challenges.
- Competitive landscape: The patent’s strength depends on its position relative to prior art and competing patents in the same therapeutic area.
- Global strategy: Augmenting Israel patent rights with broader patent protection can maximize market exclusivity.
- Legal robustness: Regular patent landscape analysis is essential to safeguard against infringement or patent invalidation.
- Innovation positioning: Clear differentiation in drug formulation or delivery methods can enhance patent robustness and licensing potential.
FAQs
1. What is the typical patent life for IL241053?
The standard patent term is 20 years from the priority date, subject to maintenance fees and potential patent term adjustments.
2. Can IL241053 be challenged or invalidated?
Yes. Potential grounds include lack of novelty, obviousness, or insufficient inventive step, especially if prior art closely resembles the claims.
3. How does IL241053 affect the Israeli pharmaceutical market?
It grants exclusivity within Israel for the covered innovation, potentially enabling premium pricing and commercial advantage.
4. What are the implications for global patent protection?
Patent families related to IL241053, filed in jurisdictions like the US or EU, will determine international market exclusivity.
5. How can competitors navigate around IL241053?
By designing around the specific claims—e.g., modifying chemical structures or delivery methods within the scope—or challenging its validity through prior art submissions.
Sources
[1] Israeli Patent Law (1980, amended), applicable standards for claim clarity, patentability, and scope.
